Is it time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer? Journal Article
| Author: | Kauff, N. D. |
| Article Title: | Is it time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer? |
| Keywords: | cancer survival; treatment outcome; survival rate; gene mutation; clinical trial; cisplatin; paclitaxel; cancer staging; follow up; cytoreductive surgery; ovarian neoplasms; ovary cancer; genotype; editorial; combination chemotherapy; brca1 protein; brca2 protein; risk reduction; genetic screening; germ-line mutation |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 1 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-01-01 |
| Start Page: | 9 |
| End Page: | 10 |
| Language: | English |
| DOI: | 10.1200/jco.2007.14.0244 |
| PUBMED: | 18165631 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 13" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus" |
